The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry

摘要: Abstract OBJECTIVES This study presents clinical data from the first large registry of aortic counterpulsation, a computerized database that incorporates prospectively gathered on indications for intra-aortic balloon counterpulsation (IABP) use, patient demographics, concomitant medication and in-hospital outcomes complications. BACKGROUND The pump is widely used to provide circulatory support patients experiencing hemodynamic instability due myocardial infarction, cardiogenic shock, or in very high risk undergoing angioplasty coronary artery bypass grafting. METHODS Between June 1996 August 2000, 203 hospitals worldwide (90% U.S., 10% non-U.S.) collected 16,909 case records (68.8% men, 31.2% women; mean age 65.9 ± 11.7 years). RESULTS most frequent use IABP were as follows: during after cardiac catheterization (20.6%), shock (18.8%), weaning cardiopulmonary (16.1%), preoperative (13.0%) refractory unstable angina (12.3%). Major complications (major limb ischemia, severe bleeding, leak, death directly insertion failure) occurred 2.6% cases; mortality was 21.2% (11.6% with place). Female gender, peripheral vascular disease independent predictors serious complication. CONCLUSIONS provides useful tool monitoring evolving practice IABP. In modern-day IABP, complication rates are generally low, although remains high. There an increased major women, older disease.